Biosino taps into Canadian market after its products becomes the first Chinese clinical chemistry reagents registered in Canada.
In June 2013, BioSino obtained the quality management system certification ISO13485 & ISO9001 by TUV SUD, a quality systems registrar accredited under the Canadian Medical Devices Conformity Assessment Scheme (CMDCAS).The company’s clinical chemistry diagnostic reagent products also obtained the licenses issued by Health Department of Canada.
Earlier, BioSino was granted EU's CE certification and signed strategic partnership agreement with Abbott, the world leading medical diagnostic maker. “Stepping into the Canadian market is another leap forward in BioSino’s international market strategy. It signals a milestone for BioSino in serving global clients,” says BioSino President Wu Lebin.